CASE COMMENT : UNILATERAL PRACTICES - ABUSE OF DOMINANCE - APPLICABLE LAW

Applicable law: The French Competition Authority justifies the exclusive application of Community law while assessing dominance (GlaxoSmithKline)

KEYWORDS
References

à l’encontre du laboratoire GlaxoSmithKline

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. Attention is also drawn to Decision No. 04-D-77

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

This document is protected by copyright laws and international copyright treaties. Non-authorised use of this document constitutes a violation of the publisher's rights and may be punished by up to 3 years imprisonment and up to a € 300 000 fine (Art. L 335-2 Code de la Propriété Intellectuelle). Personal use of this document is authorised within the limits of Art. L 122-5 CPI and DRM protection.